Corpus Intelligence IC Memo — LAKEVIEW MEDICAL CENTER OF RICE LAKE 2026-04-26 04:04 UTC
IC Memo — LAKEVIEW MEDICAL CENTER OF RICE LAKE
Investment Committee Memorandum | WI | 40 beds | Grade B | EBITDA uplift $10.1M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

LAKEVIEW MEDICAL CENTER OF RICE LAKE

CCN 520011 | BARRON, WI | 40 beds | April 26, 2026
EBITDA BridgeData Room
B
Investability

1. Target Overview & Investment Thesis

LAKEVIEW MEDICAL CENTER OF RICE LAKE is a 40-bed suburban community hospital in BARRON, WI with $137.4M in net patient revenue and a -12.0% operating margin. The hospital serves a payer mix of 32.1% Medicare, 3.0% Medicaid, and 64.8% commercial.

Thesis: Turnaround. Our ML models identify $10.1M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -12.0% to -4.6% (+736bps).

Net Revenue HCRIS$137.4M
Current EBITDA COMPUTED$-16.4M
Operating Margin COMPUTED-12.0%
Occupancy HCRIS44.2%
Revenue / Bed COMPUTED$3.4M
Net-to-Gross HCRIS39.0%
Distress Probability ML46.9%

2. Market Context & Competitive Position

150
WI Hospitals
0.4%
State Median Margin
89
Comparable Hospitals

WI has 150 Medicare-certified hospitals with a median operating margin of 0.4%. The target's margin of -12.0% places it below the state median. Among 89 size-comparable peers (20-80 beds), the median margin is 2.0%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (20-80), prioritizing same-state peers. 89 hospitals in the comp set.

HospitalStateBedsRevenueMargin
LAKEVIEW MEDICAL CENTER OF RIC (Target)WI40$137.4M-12.0%
MERCY WALWORTH HOSPITALWI25$616.4M4.4%
ST. JOSEPHS COMM. HOSPT.WI70$436.8M66.1%
ST. AGNES HOSPITALWI77$275.9M-3.0%
AURORA MEDICAL CENTER OF OSHKOWI79$222.3M17.9%
MARSHFIELD MEDICAL CENTER-EAU WI56$214.6M-21.8%
MONROE CLINICWI58$195.3M-4.4%
ASPIRUS RIVERVIEW HOSPITAL & CWI44$161.3M13.1%
MEMORIAL MEDICAL CENTER INC.WI25$138.4M8.1%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $10.1M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$2.9M+210bp18mo
Cost to Collect4.5%2.5%$2.7M+200bp12mo
Denial Rate Reduction12.0%6.5%$2.7M+198bp12mo
A/R Days Reduction5200.0%3800.0%$1.7M+122bp9mo
Clean Claim Rate88.0%96.0%$88K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$2.9M
Cost to Collect
$2.7M
Denial Rate Reduction
$2.7M
A/R Days Reduction
$1.7M
Clean Claim Rate
$88K
Total EBITDA Uplift$10.1M
Current EBITDA$-16.4M
+ RCM Uplift+$10.1M
Pro Forma EBITDA$-6.3M
Current Margin-12.0%
Pro Forma Margin-4.6%
WC Released (1x)$5.3M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-25.3M$-7.3M0.00x-100.0%
Base (11x exit)10.0x11.0x$-25.3M$-16.3M0.00x-100.0%
Bull Case9.0x11.0x$-22.8M$8.9M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-22.8M$3.0M0.00x-100.0%
Bear Case11.0x10.0x$-27.8M$-49.7M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-27.8M$-63.7M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 89 hospitals with 20-80 beds
  • Same-state prioritization (n=90)
  • Comp margins: P25=-8.0% / P50=2.0% / P75=8.6%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.